ANI Pharmaceuticals Inc (ANIP)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 279,593 | 267,927 | 252,953 | 222,842 | 196,707 | 164,419 | 149,212 | 142,222 | 138,785 | 136,357 | 127,876 | 114,896 | 100,610 | 91,252 | 86,957 | 85,338 | 87,157 | 80,412 | 75,296 | 70,233 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $279,593K ÷ $—K
= —
The payables turnover ratio for ANI Pharmaceuticals Inc is not provided in the financial data available. The payables turnover ratio is a liquidity ratio that measures how efficiently a company manages its trade credit by comparing the amount of purchases a company makes on credit to the average accounts payable balance. It provides insight into how quickly a company pays off its suppliers.
Without the specific data on payables turnover, we are unable to analyze ANI Pharmaceuticals Inc's efficiency in managing its accounts payable and how promptly it pays its suppliers. This ratio is valuable in assessing the company's relationship with its suppliers and its cash flow management. It is advisable for stakeholders to closely monitor this ratio to understand the company's liquidity position and ability to meet its short-term obligations.
Peer comparison
Dec 31, 2024